López-Herce Jesús, Casado Elisa, Díez Marta, Sánchez Amelia, Fernández Sarah Nicole, Bellón Jose María, Santiago Maria José
Pediatric Intensive Care Department, Gregorio Marañón General University Hospital, Madrid, Spain.
Pediatrics Department, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Int J Artif Organs. 2020 Feb;43(2):119-126. doi: 10.1177/0391398819876294. Epub 2019 Sep 23.
Acute kidney injury is a frequent complication in patients requiring extracorporeal membrane oxygenation. A single-center retrospective analysis from a prospective observational database assessing the incidence of acute kidney injury in children undergoing extracorporeal membrane oxygenation, the use of continuous renal replacement therapy and its association with outcomes was performed. One hundred children were studied. Creatinine was normal in 33.3% of children at the beginning of extracorporeal membrane oxygenation, between 1.5 and 2 times its baseline levels in 18.4% of children (stage I acute kidney injury), between 2 and 3 times baseline levels (stage II) in 20.7%, and over 3 times baseline levels or requiring continuous renal replacement therapy (stage III) in 27.6% of the patients. Eighteen patients were on continuous renal replacement therapy before the beginning of extracorporeal membrane oxygenation, 81 required continuous renal replacement therapy during extracorporeal membrane oxygenation, and 38 after weaning from extracorporeal membrane oxygenation, but none of them did at discharge from the pediatric intensive care unit. Fifty-one children survived to pediatric intensive care unit discharge. Mortality was lower in children with normal kidney function or with stage I acute kidney injury at the beginning of extracorporeal membrane oxygenation than in those with stage II or III acute kidney injury (33.3% vs 58.3%, p = 0.021). Mortality in children requiring continuous renal replacement therapy during extracorporeal membrane oxygenation was 54.3% and 21.1% in the rest of patients (p < 0.01). We conclude that kidney function is significantly impaired in a high percentage of children undergoing extracorporeal membrane oxygenation and many of them are treated with continuous renal replacement therapy. Patients treated with continuous renal replacement therapy have a higher mortality than those with normal kidney function or stage I acute kidney injury at the beginning of extracorporeal membrane oxygenation. Most patients surviving to pediatric intensive care unit discharge recover normal renal function after weaning from extracorporeal membrane oxygenation.
急性肾损伤是需要体外膜肺氧合治疗的患者中常见的并发症。我们进行了一项单中心回顾性分析,该分析来自一个前瞻性观察数据库,评估接受体外膜肺氧合治疗的儿童急性肾损伤的发生率、持续肾脏替代治疗的使用情况及其与预后的关系。共研究了100名儿童。在体外膜肺氧合开始时,33.3%的儿童肌酐正常,18.4%的儿童肌酐水平为基线的1.5至2倍(I期急性肾损伤),20.7%的儿童肌酐水平为基线的2至3倍(II期),27.6%的患者肌酐水平超过基线的3倍或需要持续肾脏替代治疗(III期)。18名患者在体外膜肺氧合开始前接受持续肾脏替代治疗,81名患者在体外膜肺氧合期间需要持续肾脏替代治疗,38名患者在体外膜肺氧合撤机后需要持续肾脏替代治疗,但在儿科重症监护病房出院时均无需持续肾脏替代治疗。51名儿童存活至儿科重症监护病房出院。体外膜肺氧合开始时肾功能正常或I期急性肾损伤的儿童死亡率低于II期或III期急性肾损伤的儿童(33.3%对58.3%,p = 0.021)。体外膜肺氧合期间需要持续肾脏替代治疗的儿童死亡率为54.3%,其余患者为21.1%(p < 0.01)。我们得出结论,接受体外膜肺氧合治疗的儿童中,很大一部分肾功能严重受损,其中许多人接受了持续肾脏替代治疗。与体外膜肺氧合开始时肾功能正常或I期急性肾损伤的患者相比,接受持续肾脏替代治疗的患者死亡率更高。大多数存活至儿科重症监护病房出院的患者在体外膜肺氧合撤机后肾功能恢复正常。